Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Control of hyperphosphatemia beyond phosphate.

P Evenepoel1

  • 1Department of Medicine, Division of Nephrology, University Hospital Leuven, Leuven, Belgium. Pieter.Evenepoel@uz.kuleuven.ac.be

Kidney International
|February 23, 2007
PubMed
Summary

Hyperphosphatemia is common in dialysis patients. Sevelamer, a phosphate binder, may improve survival in these patients, offering a significant clinical benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease.

The Journal of endocrinology·2023
Same author

Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Vitamin K in CKD Bone Disorders.

Calcified tissue international·2021
Same author

Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey.

Journal of endocrinological investigation·2020
Same author

Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism.

Calcified tissue international·2020
Same author

Reply to: Poor Vitamin K Status in Chronic Kidney Disease: An Indirect Indicator of Hip Fragility.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2019

Area of Science:

  • Nephrology
  • Mineral Metabolism

Background:

  • Hyperphosphatemia is a common complication in patients undergoing dialysis.
  • Elevated phosphate levels are linked to adverse health outcomes in this population.

Discussion:

  • A post hoc analysis suggests sevelamer, a non-calcium-based phosphate binder, may enhance survival.
  • This finding is significant as it's the first intervention study in mineral metabolism to demonstrate an effect on a hard clinical endpoint.

Key Insights:

  • Sevelamer shows potential for improving survival in incident hyperphosphatemic hemodialysis patients.
  • The study highlights the importance of phosphate management in dialysis care.

Outlook:

  • Further research is warranted to confirm these survival benefits in broader patient cohorts.
  • This study may influence future treatment guidelines for hyperphosphatemia in dialysis patients.

Related Experiment Videos